FDA Clinical Hold Removed for Histogen Trial in Knee Regeneration
Histogen can proceed with a Phase I/II clinical trial examining human extracellular matrix plus microfracture to regenerate hyaline cartilage....
Histogen can proceed with a Phase I/II clinical trial examining human extracellular matrix plus microfracture to regenerate hyaline cartilage....
The trial is examining MOTYS placental tissue particulate in the treatment of osteoarthritis of the knee....
StemSpine is the company's regenerative stem cell procedure for the treatment of degenerative disc disease....
The study is investigating Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord for pain relief and functional improvement....
The TheraFuze DBF Fiber Bag is now available for use in spinal and orthopedic surgeries, including minimally invasive procedures. ...
The biomimetic graft for osteochondral lesions is the company's second Breakthrough Device designation granted in 2021....
First patients are enrolled in AlloSource's study of the amniotic membrane for 2-level anterior cervical discectomy and fusion....
The processed demineralized cortical fiber allograft is available in moldable fiber and strip formats....
MgNum BVF comprises magnesium, phosphates and a proprietary solution. It has 3x the compressive strength of cancellous bone and adhesive...
FDA approved an IND Application to study Signature Cord Prime in patients with symptomatic osteoarthritis of the knee....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.